JSS Investmentfonds II - JSS Sustainable Equity - Future Health C Fonds
89,33
CHF
-0,79
CHF
-0,88
%
NAV
Werbung
Anlageziel
The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs.
Stammdaten
| Name | JSS Investmentfonds II - JSS Sustainable Equity - Future Health C CHF Acc Fonds |
| ISIN | LU2041626032 |
| WKN | A2PWQ3 |
| Fondsgesellschaft | J. Safra Sarasin Fund Management (Luxembourg) S.A. |
| Benchmark | No benchmark |
| Ausschüttungsart | Thesaurierend |
| Manager | Jean-Charles Belvo, Tomasz Godziek, Simone Poma, Leonildo Delgado |
| Domizil | Luxembourg |
| Fondskategorie | Aktien |
| Auflagedatum | 21.11.2019 |
| Geschäftsjahr | 30.04. |
| VL-fähig? | Nein |
| Depotbank | CACEIS Investor Services Bank S.A. |
| Zahlstelle | Bank J. Safra Sarasin AG |
| Riester Fonds | Nein |
Basisdaten
| Auflagedatum | 21.11.2019 |
| Depotbank | CACEIS Investor Services Bank S.A. |
| Zahlstelle | Bank J. Safra Sarasin AG |
| Domizil | Luxembourg |
| Geschäftsjahr | 30.04. |
Aktuelle Daten
| Morningstar Rating | |
| Aktueller Rücknahmepreis | 89,33 |
| Anzahl Fonds der Kategorie | 812 |
| Volumen der Tranche | 15,17 Mio. CHF |
| Fondsvolumen | 121,66 Mio. CHF |
| Total Expense Ratio (TER) | 1,38 |
Gebühren
| Laufende Kosten | 2,35% |
| Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 1,38% |
| Transaktionskosten | 0,97% |
| Depotbankgebühr | - |
| Managementgebühr | 1,00% |
| Rücknahmegebühr | - |
| Ausgabeaufschlag | 3,00% |
Performancedaten
| Veränderung Vortag | -0,79 |
| WE seit Jahresbeginn | -9,57% |